NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Cannabis doubles car crash risk
Fri February 10th - Cannabis users who drive within three hours of taking the drug are at double the risk of crashing than those who are not under the influence of alcohol or drugs, researchers said today. More
Planned caesarean carries lowest severe bleeding risk
Fri February 10th - Severe bleeding after giving birth is much less likely with a planned caesarean, Danish researchers have found. More
Travel Ideas
Travel Books and Maps
OTHER NEWS OF INTEREST
ENGLEMED HEALTH NEWS

New flu vaccine hope

Tues April 28th, 2009

Vaccine experts gathered for a major conference yesterday as fear of swine flu swept the world - and offered hope of a universal flu vaccine.

Current flu vaccines seek to predict the strains of flu that will be at large - and unexpected new strains can leave them ineffective.

Yesterday's conference heard the first steps had been taken towards a universial vaccine - which would reinforce seasonal vaccines.

Some 377 healthy adults have already tested a universal vaccine, which showed early signs of working, the National Foundation for Infectious Disease Conference for Vaccine Research in Baltimore, Maryland, USA, heard.

The volunteers received low doses of vaccine and showed signs of an immune system response.

Researcher Dr Robert Belshe, of the St Louis University, USA, said: "This is a significant first step in developing a universal vaccine to help protect against pandemic influenza.

"Novel vaccines, capable of inducing long-lasting, broad immunity against divergent strains, including potential pandemic viruses, are highly desirable."

The vaccine, known as Bivalent Influenza Peptide Conjugate Vaccine (BIPCV), is made with proteins from strains of influenza A and B.

Discuss this report here

Tags: Flu & Viruses | World Health | North America

CATEGORIES